SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.02.15 | Roche buy | Jefferies & Company Inc. | |
12.02.15 | Roche overweight | Barclays Capital | |
09.02.15 | Novartis buy | Citigroup Corp. | |
09.02.15 | Roche Neutral | Citigroup Corp. | |
09.02.15 | Roche overweight | JP Morgan Chase & Co. | |
02.02.15 | Roche Hold | Kepler Cheuvreux | |
29.01.15 | Roche buy | Deutsche Bank AG | |
29.01.15 | Roche overweight | Morgan Stanley | |
28.01.15 | Novartis neutral | Morgan Stanley | |
28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
28.01.15 | Novartis Hold | Deutsche Bank AG | |
28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.01.15 | Novartis Halten | Independent Research GmbH | |
26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
26.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.01.15 | Roche Outperform | BNP PARIBAS | |
22.01.15 | Novartis Outperform | BNP PARIBAS | |
22.01.15 | Novartis buy | UBS AG | |
22.01.15 | Roche Neutral | UBS AG | |
21.01.15 | Novartis neutral | Morgan Stanley | |
21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
20.01.15 | Novartis Equal-Weight | Morgan Stanley | |
20.01.15 | Roche kaufen | Morgan Stanley | |
20.01.15 | Novartis neutral | Independent Research GmbH | |
19.01.15 | Roche kaufen | Independent Research GmbH | |
19.01.15 | Roche Hold | Kepler Cheuvreux | |
19.01.15 | Novartis buy | Kepler Cheuvreux | |
16.01.15 | Roche Hold | S&P Capital IQ | |
16.01.15 | Novartis buy | UBS AG | |
16.01.15 | Roche Neutral | UBS AG | |
16.01.15 | Novartis buy | Jefferies & Company Inc. | |
16.01.15 | Roche buy | Jefferies & Company Inc. | |
16.01.15 | Novartis buy | S&P Capital IQ | |
16.01.15 | Roche overweight | Barclays Capital | |
16.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
15.01.15 | Novartis Hold | Deutsche Bank AG | |
15.01.15 | Roche buy | Deutsche Bank AG |